Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

IL-6-STAT3 axis is known as a key factor of tumor progression. In this issue of Immunity, Yu and colleagues (2016) show that IL-6-binding CD5, rather than IL-6 receptor-α in B cells, amplifies STAT3 activation via JAK-STAT signaling to promote cancer. Copyright © 2016 Elsevier Inc. All rights reserved.

Citation

Kazuya Masuda, Tadamitsu Kishimoto. CD5: A New Partner for IL-6. Immunity. 2016 Apr 19;44(4):720-2

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 27096313

View Full Text